FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Levinsohn Ross 2. Date of Event Requiring Statement (MM/DD/YYYY)
8/26/2020 

3. Issuer Name and Ticker or Trading Symbol theMaven, Inc. [MVEN]
(Last)       (First)       (Middle)
225 LIBERTY STREET, 27TH FLOOR
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Executive Officer /
(Street)
NEW YORK, NY 10281      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  245434  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase   (1) 4/10/2029  Common Stock  532004  $0.46  D   
Option to purchase   (2) 6/19/2029  Common Stock  2000000  $0.42  D   
Option to purchase   (3) 9/16/2029  Common Stock  2000000  $0.81  D   

Explanation of Responses:
(1)  The option shall be subject to vesting (i) based on the achievement by the Issuer of stock price and liquidity targets and (ii) a concurrent 36-month vesting period with a 12-month cliff. The ability to exercise is subject to both: i) vesting conditions (listed in the preceding sentence) and ii) the Issuer's Board of Directors approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant.
(2)  1/3 vest after 1 year. Balance vests monthly over next 2 years. Grant is pending an amendment to the Issuer's Certificate of Incorporation increasing the number of authorized shares of Common Stock to allow for exercise of the grant.
(3)  1/3 vest after 1 year. Balance vests monthly over next 2 years. Grant is pending an amendment to the Issuer's Certificate of Incorporation increasing the number of authorized shares of Common Stock to allow for exercise of the grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Levinsohn Ross
225 LIBERTY STREET, 27TH FLOOR
NEW YORK, NY 10281
X
Chief Executive Officer

Signatures
/s/ Ross Levinsohn 12/29/2020
**Signature of Reporting Person Date